Prevalence of Vaccination Rates in Systolic Heart Failure: A Prospective Study of 549 Patients by Age, Race, Ethnicity, and Sex in a Heart Failure Disease Management Program

Congestive Heart Failure

Volumn 16, Issue 6, 2010, Pages 278-283

  Hebert, Kathy ^a   Marzouka, George ^a   Arcement, Lee ^b   Julian, Elyse ^a   Cortazar, Frank ^a   Dias, Andre ^a   Tamariz, Leonardo ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Leonard J Chabert Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

ADULT; ARTICLE; CALCULATION; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; ETHNICITY; FEMALE; FOLLOW UP; GROUPS BY AGE AND SEX; HEART EJECTION FRACTION; HUMAN; INFLUENZA; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; PNEUMOCOCCAL INFECTION; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE; STANDARDIZATION; SYSTOLIC HEART FAILURE; VACCINATION;

AGE FACTORS; CONFIDENCE INTERVALS; CONTINENTAL POPULATION GROUPS; DISEASE MANAGEMENT; ETHNIC GROUPS; FEMALE; HEART FAILURE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; ODDS RATIO; OUTPATIENTS; PNEUMOCOCCAL VACCINES; PREVALENCE; PROGRAM EVALUATION; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; SEX FACTORS; STATISTICS AS TOPIC; STROKE VOLUME; SYSTOLE; UNITED STATES; VACCINATION; VENTRICULAR FUNCTION, LEFT;

EID: 78649466235     PISSN: 15275299     EISSN: 17517133     Source Type: Journal    
DOI: 10.1111/j.1751-7133.2010.00190.x     Document Type: Article

References (23)

1. Fiore AE, Shay DK, Broder K, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep. 2009;58(RR-8):1-52.
2. Sprenger MJ, Mulder PG, Beyer WE, et al. Impact of influenza on mortality in relation to age and underlying disease, 1967-1989. Int J Epidemiol. 1993;22(2):334-340.
3. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289(2):179-186.
4. Nichol KL, Nordin J, Mullooly J, et al. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med. 2003;348(14):1322-1332.
5. Siscovick DS, Raghunathan TE, Lin D, et al. Influenza vaccination and the risk of primary cardiac arrest. Am J Epidemiol. 2000;152(7):674-677.
6. Gurfinkel EP, Leon de la Fuente R, Mendiz O, Mautner B. Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study. Eur Heart J. 2004;25(1):25-31.
7. Wang CS, Wang ST, Lai CT, et al. Impact of influenza vaccination on major cause-specific mortality. Vaccine. 2007;25(7):1196-1203.
8. De Diego C, Vila-Corcoles A, Ochoa O, et al. Effects of annual influenza vaccination on winter mortality in elderly people with chronic heart disease. Eur Heart J. 2009;30(2):209-216.
9. Rosner F, Zarrabi MH. Risk factors for acquiring pneumococcal infections. Arch Intern Med. 1987;147(2):212.
10. Hunt SA, American College of Cardiology, American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2005;46(6):e1-e82.
11. U.S. Department of Health and Human Services: Office of Disease Prevention and Health Promotion - Healthy People 2010. Nasnewsletter. 2000;15(3):3.
12. Bittner V, Sanderson BK. Influenza vaccination in secondary prevention: an opportunity missed. J Cardiopulm Rehabil Prev. 2007;27(4):202-207.
13. Singleton JA, Santibanez TA, Wortley PM. Influenza and pneumococcal vaccination of adults aged > or = 65: racial/ethnic differences. Am J Prev Med. 2005;29(5):412-420.
14. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1997;46(RR-8):1-24.
15. Todd WE, Nash D Disease Management: A Systems Approach to Improving Patient Outcomes. Hoboken, NJ: Jossey-Bass; 2001:382.
16. Bernard DB, Townsend RR, Sylvestri MF. Health and disease management: what is it and where is it going? What is the role of health and disease management in hypertension? Am J Hypertens. 1998;11(8 Pt 2):103S-108S; discussion 109S-111S.
17. Shefer A, McKibben L, Bardenheier B, et al. Characteristics of long-term care facilities associated with standing order programs to deliver influenza and pneumococcal vaccinations to residents in 13 states. J Am Med Dir Assoc. 2005;6(2):97-104.
18. Ompad DC, Galea S, Vlahov D. Distribution of influenza vaccine to high-risk groups. Epidemiol Rev. 2006;28:54-70.
19. Straits-Troster KA, Kahwati LC, Kinsinger LS, et al. Racial/ethnic differences in influenza vaccination in the Veterans Affairs Healthcare System. Am J Prev Med. 2006;31(5):375-382.
20. Appel A, Everhart R, Mehler PS, MacKenzie TD. Lack of ethnic disparities in adult immunization rates among underserved older patients in an urban public health system. Med Care. 2006;44(11):1054-1058.
21. Armstrong K, Berlin M, Schwartz JS, et al. Barriers to influenza immunization in a low-income urban population. Am J Prev Med. 2001;20(1):21-25.
22. Daniels NA, Juarbe T, Rangel-Lugo M, et al. Focus group interviews on racial and ethnic attitudes regarding adult vaccinations. J Natl Med Assoc. 2004;96(11):1455-1461.
23. Lainscak M, Cleland JG, Lenzen MJ, et al. Recall of lifestyle advice in patients recently hospitalised with heart failure: a EuroHeart Failure Survey analysis. Eur J Heart Fail. 2007;9(11):1095-1103.